Comparison of endometrial biopsy with the endometrial pipelle and vabra aspirator

This study compares outpatient endometrial sampling using the Pipelle endometrial sampling curette with conventional dilation and curettage (D&C) in patients with abnormal uterine bleeding. Endometrial sampling with the Pipelle curette was performed in 172 and D&C in 97 women. No complications were encountered with either of these procedures. One hundred and seventy (98.8%) of the Pipelle aspirations attempted were successfully completed. Sufficient material for histological assessment was obtained in 154 (90.6%) of the women who underwent Pipelle endometrial sampling and in only 66 (68%) of those who underwent D&C (p < 0.0001). In postmenopausal women, adequate specimens were obtained in 74 of 88 (84.1 %) by Pipelle and in only 22 of 48 (45.8%) by D&C. In 45 cases the histologic diagnosis of the endometrium obtained by Pipelle sampling was compared with the one of endometrium obtained by D&C or hysterectomy performed shortly thereafter. The diagnosis was identical in 43 (95.5%) cases. Endometrial sampling with the Pipelle was well tolerated causing occasionally only slight discomfort.

“…Kaunitz et al [9] found no cases of endometrial carcinoma among 30 outpatients who underwent Pipelle endometri al biopsy for abnormal bleeding. Eddowes et al…”

Section: Discussionmentioning

confidence: 99%

Outpatient Endometrial Sampling with the Pipelle Curette

Ben‐Baruch

Seidman

Schiff

et al. 1994

“…This newer instrument has the advantage that it can pass through most endocervical canals without dilatation or the use of a tenaculum. The Pipelle device has been shown to be an easily applicable inexpensive tool that provides adequate tissue specimens with minimal patient discomfort [2][3][4][5][6],…”

Section: Introductionmentioning

confidence: 99%

Accuracy of Pipelle Endometrial Sampling in Endometrial Carcinoma

Zorlu

Çobanoğlu

Işık

et al. 1994

In this prospective study, we compared the histological results of Pipelle endometrial sampling (PES) with that of hysterectomy to examine whether endometrial sampling with the Pipelle device can accurately diagnose endometrial carcinoma. PES was performed in 26 patients with known endometrial carcinoma whose initial therapy consisted of hysterectomy. Discomfort and pain during the biopsy were reported to be mild by 22 patients, moderate by 3 patients and severe by only 1 patient. All of the samples were found to be adequate. Twenty-four of 26 PES confirmed endometrial carcinoma, a correlation of 95%, and the histological grade reported on PES agreed with that of hysterectomy specimens in 87.5% of the patients. On the other hand, the tumor grade in the specimens obtained at dilation and curettage correlated with hysterectomy specimens in 95% of the patients. We conclude that Pipelle is an accurate device in patients with endometrial carcinoma.

“…Kaunitz et al [8] confirmed that Pipelle was less painful than Vabra in 50 cases (89%) compared with 2 Vabra cases (4%). In our study, the pathology results were equal for both techniques, and insufficient tissue did not differ between Vabra and Endocell (46/184, 25.0% vs. 50/183, 27.3%).…”

Section: Discussionmentioning

confidence: 62%

Compared Randomized Roles and Pain Factor by Vabra and Wallach Endocell in Endometrial Evaluation

Lambert

Gonthier

Déry

et al. 1998

This randomized study was carried out to compare pain factors of Vabra and Endocell by an ordered classification of one to ten to evaluate the respective pathological yield and to establish the clinical acceptability. Patients had endometrial evaluation either for abnormal bleeding, abnormal endometrial line as demonstrated by echography or abnormal endometrial cells in the Pap smear. Age, gravidity, parity and hysterometry were similar in both groups, with abnormal bleeding being the most frequent indication (250/370 patients, 67.5%). Both techniques yielded equal results for insufficient tissue retrieval at 46/184 (25.0%) for Vabra and at 50/183 (27.3%) for Endocell. The pain score differed significantly in favor of Wallach Endocell at 4.36 ± 2.38 versus Vabra at 5.65 ± 2.41 (p = 0.001). Vabra and Endocell give similar pathological results; however, Endocell is significantly less painful and easier to manipulate and carry because of its weight (1.69 g vs. 37.80 g).